Product Information

ASTAGRAF XL 1 MG CAPSULE is a brand product labeled by Astellas Pharma US, Inc., priced at $5.7032 per EA under NDC 00469067773. Its NADAC has been published 357 times since Jan 22, 2020.

FDA first approved this application on Jul 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ASTAGRAF XL 1 MG CAPSULE

tacrolimus extended-release capsules
$5.7032per EA

Strength

1 mg/1

NDC

00469067773

Classification

Brand

Dosage Form

CAPSULE, COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TACROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA204096

FDA Approved

7/19/2013

TE Code

AB

On Market Since

7/19/2013

Pharmacological Classes

Price Statistics

The NADAC for ASTAGRAF XL 1 MG CAPSULE has been published 357 times since Jan 22, 2020, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.

Current price$5.7032 per EA
All-time high$5.7091 (Nov 11, 2026)
All-time low$4.5486 (Jan 22, 2020)
52-week high$5.7091
52-week low$5.4946
Median price$5.2591
Average price$5.1423
Largest weekly change+6.0% (Jan 25, 2023)
Weeks tracked357
Tracking sinceJan 22, 2020

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

+0.8%

1Y

+3.5%

3Y

+8.4%

5Y

+21.7%

All

+25.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tacrolimus extended-release capsules market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ASTAGRAF XL 1 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ASTAGRAF XL 1 MG CAPSULE, manufactured by Astellas Pharma US, Inc., is $5.7032 per EA (NDC 00469067773), effective Nov 18, 2026.

How has the price of ASTAGRAF XL 1 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ASTAGRAF XL 1 MG CAPSULE has risen 25.4%. It has been tracked across 357 weekly CMS publications since Jan 22, 2020.

What are the highest and lowest recorded NADAC prices for ASTAGRAF XL 1 MG CAPSULE?

Since Jan 22, 2020, the NADAC for ASTAGRAF XL 1 MG CAPSULE has ranged from a low of $4.5486 (Jan 22, 2020) to a high of $5.7091 (Nov 11, 2026), with a median of $5.2591 per EA.

Are there cheaper alternatives to ASTAGRAF XL 1 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ASTAGRAF XL 1 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ASTAGRAF XL 1 MG CAPSULE?

ASTAGRAF XL 1 MG CAPSULE (NDC 00469067773) is labeled by Astellas Pharma US, Inc., and CMS classifies it as a brand product.